[go: up one dir, main page]

GB201713852D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB201713852D0
GB201713852D0 GBGB1713852.0A GB201713852A GB201713852D0 GB 201713852 D0 GB201713852 D0 GB 201713852D0 GB 201713852 A GB201713852 A GB 201713852A GB 201713852 D0 GB201713852 D0 GB 201713852D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1713852.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repos Pharma AB
Original Assignee
Repos Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repos Pharma AB filed Critical Repos Pharma AB
Priority to GBGB1713852.0A priority Critical patent/GB201713852D0/en
Publication of GB201713852D0 publication Critical patent/GB201713852D0/en
Priority to PCT/EP2018/073365 priority patent/WO2019043108A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1713852.0A 2017-08-30 2017-08-30 Cancer treatment Ceased GB201713852D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1713852.0A GB201713852D0 (en) 2017-08-30 2017-08-30 Cancer treatment
PCT/EP2018/073365 WO2019043108A1 (en) 2017-08-30 2018-08-30 Cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1713852.0A GB201713852D0 (en) 2017-08-30 2017-08-30 Cancer treatment

Publications (1)

Publication Number Publication Date
GB201713852D0 true GB201713852D0 (en) 2017-10-11

Family

ID=60037300

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1713852.0A Ceased GB201713852D0 (en) 2017-08-30 2017-08-30 Cancer treatment

Country Status (2)

Country Link
GB (1) GB201713852D0 (en)
WO (1) WO2019043108A1 (en)

Also Published As

Publication number Publication date
WO2019043108A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
IL271946A (en) Combination cancer therapy
ZA201905902B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
PT3576740T (en) Cancer treatment
IL263123A (en) Cancer treatments
IL259996A (en) Combinations for the treatment of cancer
IL268463A (en) Cancer treatment
GB201706451D0 (en) Cancer treatment
IL247859A0 (en) Cancer treatment
IL274626A (en) Cancer treatment
ZA201707024B (en) Cancer treatment composition
IL260814A (en) Cancer treatment
GB201707864D0 (en) Platinum-reistant cancer treatment
IL274748A (en) Improved treatment of cancer
GB201522433D0 (en) Cancer treatment
GB201519734D0 (en) Cancer therapy
GB201718985D0 (en) Treatment
GB201704909D0 (en) Cancer therapy
GB201819920D0 (en) Cancer treatment
GB201711855D0 (en) Cancer therapy
GB201713852D0 (en) Cancer treatment
GB201811431D0 (en) Cancer treatment
GB201804816D0 (en) Cancer treatment
GB201720533D0 (en) Cancer treatments
GB201711250D0 (en) Cancer therapy
GB201710198D0 (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)